Refine
Year of publication
Language
- English (22)
Has Fulltext
- yes (22)
Is part of the Bibliography
- no (22)
Keywords
- acute-on-chronic liver failure (3)
- inflammation (3)
- ACLF (2)
- Cirrhosis (2)
- Inflammation (2)
- Liver diseases (2)
- cirrhosis (2)
- hepatitis C virus (2)
- resistance mutation (2)
- serine protease (NS3-4A) (2)
- Ascites (1)
- Blood plasma (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- Case report (1)
- Cell cultures (1)
- Clinical phenotype (1)
- Crystal structure (1)
- Dimers (Chemical physics) (1)
- Eicosanoids (1)
- Fatty acids (1)
- Fatty liver (1)
- Frameshift (1)
- GSK3α (1)
- GSK3β (1)
- Gastrointestinal tract (1)
- Intracellular pathogens (1)
- Liver (1)
- Liver fibrosis (1)
- MEN1 (1)
- Microbial mutation (1)
- NASH (1)
- NS5A (1)
- RNA virus (1)
- RNA viruses (1)
- Truncating mutation (1)
- Viral core (1)
- Viral replication (1)
- Vitamin D (1)
- Vitamin D deficiency (1)
- acute‐on‐chronic liver failure (1)
- adaptation (1)
- alcoholic fatty liver disease (1)
- arachidonic acid (1)
- ascites (1)
- bacterial translocation (1)
- circulation (1)
- cytokines (1)
- decompensated liver cirrhosis (1)
- drug resistance (1)
- evolution (1)
- exosomes (1)
- fibrosis (1)
- hemodynamic (1)
- hepatitis C virus (HCV) (1)
- hepatitis E virus (1)
- hospital admission (1)
- host-targeting antivirals (1)
- immune escape (1)
- innate immunity (1)
- insulin resistance (1)
- interactions (1)
- interferon (1)
- interferons (1)
- lipid droplets (1)
- lipidomics (1)
- liver cirrhosis (1)
- liver immunology (1)
- macrophages (1)
- male (1)
- mechanical ventilation (1)
- membrane remodeling (1)
- metabolomics (1)
- miR-122 (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular dynamics (1)
- mortality (1)
- non-alcoholic fatty liver disease (1)
- omega-3 fatty acids (1)
- phospholipid (1)
- portal hypertension (1)
- protease inhibitor (1)
- protein evolution (1)
- protein folding (1)
- pulmonary failure (1)
- replicative fitness (1)
- respiratory failure (1)
- structure constraints (1)
- viral fitness (1)
- viral replication (1)
Institute
- Medizin (20)
- Frankfurt Institute for Advanced Studies (FIAS) (2)
- Physik (2)
The spike protein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is required for cell entry and is the primary focus for vaccine development. In this study, we combined cryo–electron tomography, subtomogram averaging, and molecular dynamics simulations to structurally analyze S in situ. Compared with the recombinant S, the viral S was more heavily glycosylated and occurred mostly in the closed prefusion conformation. We show that the stalk domain of S contains three hinges, giving the head unexpected orientational freedom. We propose that the hinges allow S to scan the host cell surface, shielded from antibodies by an extensive glycan coat. The structure of native S contributes to our understanding of SARS-CoV-2 infection and potentially to the development of safe vaccines.
Background: While systemic inflammation is recognized as playing a central role in the pathogenesis of organ failures in patients with liver cirrhosis, less is known about its relevance in the development of classical hepatic decompensation. Aim: To characterize the relationship between systemic inflammation, hemodynamics, and anemia with decompensation of liver cirrhosis. Methods: This is a post-hoc analysis of a cohort study of outpatients with advanced liver fibrosis or cirrhosis. Results: Analysis included 338 patients of whom 51 patients (15%) were hospitalized due to decompensation of liver cirrhosis during a median follow-up time of six months. In univariate analysis, active alcoholism (p = 0.002), model of end-stage liver disease (MELD) score (p = 0.00002), serum IL-6 concentration (p = 0.006), heart rate (p = 0.03), low arterial blood pressure (p < 0.05), maximal portal venous flow (p = 0.008), and low hemoglobin concentration (p < 0.00001) were associated with hospitalization during follow-up. Multivariate analysis revealed an independent association of low hemoglobin (OR = 0.62, 95% CI = 0.51–0.78, p = 0.001) and serum IL-6 concentration (OR = 1.02, 95% CI = 1.01–1.04, p = 0.03)—but not of hemodynamic parameters—with hepatic decompensation. An inverse correlation between hemoglobin concentration and portal venous flow (R = −0.362, p < 0.0001) was detected for the non-hospitalized patients. Accuracy of baseline hemoglobin levels for predicting hospitalization (AUC = 0.84, p < 0.000001) was high. Conclusion: Anemia and systemic inflammation, rather than arterial circulatory dysfunction, are strong and independent predictors of hepatic decompensation in outpatients with liver cirrhosis.